| Project Title | Phosphodiesterase Type 5 (PDE-5) Inhibitor Utilization Among Women |
| Date Posted | Friday, October 12, 2018 |
| Project ID | cder_mpl1r_wp111-112 |
| Status | Complete |
| Deliverables | |
| Related Links | |
| Description | The goal of this query was to estimate phosphodiesterase type 5 (PDE5) inhibitor utilization among women in the Sentinel Distributed Database (SDD). Report 1 contains estimates of phosphodiesterase type 5 (PDE5) inhibitor use among reproductive-aged women. Report 2 contains estimates of PDE5 inhibitor use that occurred during a pregnancy ending in a live-born delivery or within 90 days prior to pregnancy start, among women. Data from January 1, 2001 to March 31, 2018 from 16 Data Partners contributing to the SDD were included in this report. This request was distributed to Data Partners on August 27, 2018. |
| Medical Product | phosphodiesterase type 5 (PDE5) inhibitor |
| Population / Cohort | Females 15-50 years of age |
| Time Period | January 1, 2001 - March 31, 2018 |
| Assessment Type | Exploratory Analyses |
| Study Type | Modular Program |
| Data Sources | Sentinel Distributed Database (SDD) |
| FDA Center | CDER |
